Pap smears are used for purposes other than cervical cancer screening

Pap smears can help reduce the incidence of cervical cancer. A new study shows that they can also be used to detect other gynecological cancers early. The tissue and fluid collected during the Pap smear can be genetically detected to detect endometrial and ovarian cancer. Researcher Dr. Amanda Fader said that if cancers are detected, thousands of lives can be saved each year by catching these cancers at an earlier and more treatable stage.

The main goal is to be able to detect these cancers through mutations in tumor genes, which are usually found in the blood or fluids collected from the cervix and vagina. If we can detect cancer in the early or early stages of cancer, not only is it possible to get more treatment, but it will also protect many women from having more fertility.

In a Pap smear, the doctor uses a spatula or brush to collect cells from the cervix, which are then sent to the laboratory for analysis.

The researchers developed a test protocol called PapSEEK to see if other samples collected during the pelvic exam can be used to detect endometrial cancer or ovarian cancer. PapSEEK can detect DNA mutations that have been identified as specific cancers, including 18 commonly mutated genes.

To see if the test worked, the researchers collected samples from 1,658 women, 656 of whom had endometrial or ovarian cancer, and 1,000 healthy women as a control group. Studies have shown that the PapSEEK test can accurately detect 81% of endometrial cancers and 33% of ovarian cancers. When the researchers used brushes to collect samples, accurate detection increased to 93% and 45%, respectively.

This is a very early preliminary result and looks promising, but there is still a long way to go to determine whether this is really useful.

 

For details on cervical cancer treatment and second opinion, do call us at +91 96 1588 1588 or write to cancerfax@gmail.com.

Susan Hau is a distinguished researcher in the field of cancer cell therapy, with a particular focus on T cell-based approaches and cancer vaccines. Her work spans several innovative treatment modalities, including CAR T-cell therapy, TIL (Tumor-Infiltrating Lymphocyte) therapy, and NK (Natural Killer) cell therapy.

Hau's expertise lies in cancer cell biology, where she has made significant contributions to understanding the complex interactions between immune cells and tumors.

Her research aims to enhance the efficacy of immunotherapies by manipulating the tumor microenvironment and exploring novel ways to activate and direct immune responses against cancer cells.

Throughout her career, Hau has collaborated with leading professors and researchers in the field of cancer treatment, both in the United States and China.

These international experiences have broadened her perspective and contributed to her innovative approach to cancer therapy development.

Hau's work is particularly focused on addressing the challenges of treating advanced and metastatic cancers. She has been involved in clinical trials evaluating the safety and efficacy of various immunotherapy approaches, including the promising Gamma Delta T cell therapy.

  • Comments Closed
  • April 25th, 2020

Both men and women should understand cervical cancer

Previous Post:
nxt-post

Cervical cancer treatment also includes immunotherapy

Next Post:

Scan the code